gadobutrol · Injection

What changed in the last 90 days

Every detected change for gadobutrol, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Gadolinium-based Contrast Agent, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

• allium sativum, avena sativa, berberis vulgaris, lappa major, solidago virgaurea, phytolacca decandra, lycopodium clavatum, nux vomica, aluminium metallicum, antimonium crudum, argentum metallicum, arsenicum album, aurum metallicum, baryta carbonica, beryllium metallicum, bismuthum metallicum, boron, bromium, cadmium metallicum, cerium metallicum, cesium chloride, chromium, cobaltum metallicum, cuprum metallicum, dysprosium metallicum, erbium metallicum, europium metallicum, ferrum metallicum, molybdenum,· 1 maker
• gadobenate dimeglumine· 2 makers
• gadoxetate disodium· 2 makers
• gadoterate meglumine· 7 makers

Common questions

Is Gadobutrol in shortage right now?

No. FDA does not currently list Gadobutrol in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.

Who makes Gadobutrol?

7 companies have marketed Gadobutrol in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

Shortage reports for this molecule

• Planned discontinuation — Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-02)Jun 30, 2026
• Planned discontinuation — Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-07)Jun 30, 2026
• Planned discontinuation — Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-10)Jun 30, 2026
• Planned discontinuation — Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-15)Jun 30, 2026